Aardvark Therapeutics, Inc. (AARD) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time AARD price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 49.6 Neutral
Market Cap $143.8M
Volume 118.8K
Fundamentals — 10-Q Q2 2026
Revenue --
Net Income $-36.0M
EPS $-1.65
P/E Ratio -4.0x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Sun Nelson | Chief Financial Officer | Buy | 3,000 | $14.40 | $43,200 | 2025 Dec 11 |
| Lee Tien-Li | Chief Executive Officer | Buy | 7,000 | $14.49 | $101,430 | 2025 Dec 11 |
| Lee Tien-Li | Chief Executive Officer | Buy | 10,000 | $9.66 | $96,605 | 2025 Sep 15 |
| Lee Tien-Li | Chief Executive Officer | Buy | 20,000 | $8.03 | $160,610 | 2025 Sep 12 |
| Sun Nelson | Chief Financial Officer | Buy | 6,000 | $8.07 | $48,420 | 2025 Sep 9 |
| Lee Tien-Li | Chief Executive Officer | Buy | 16,542 | $16.00 | $264,672 | 2025 Feb 14 |
| Cormorant Asset Management, LP | Insider | Buy | 187,500 | $16.00 | $3.0M | 2025 Feb 14 |
| Decheng Capital Management IV (Cayman), LLC | 10% Owner | Buy | 1,250,000 | $16.00 | $20.0M | 2025 Feb 14 |
| Sun Nelson | Chief Financial Officer | Buy | 10,000 | $16.00 | $160,000 | 2025 Feb 14 |
| Creamer James W III | CFO & Treasurer | Buy | 500 | $1.90 | $950 | 2007 Aug 17 |
| Schmitt Ann L | President | Buy | 4,410 | $1.94 | $8,536 | 2007 May 25 |
| Zimlich Joseph C | Director | Buy | 56,550 | $1.30 | $73,515 | 2006 Dec 6 |
| Lagerborg Alexander V | Chief Executive Officer | Buy | 600 | $3.05 | $1,830 | 2006 May 15 |
| Creamer James W III | Chief Financial Officer | Buy | 300 | $3.05 | $915 | 2006 May 12 |
| Troska Joni K | Secretary | Buy | 200 | $3.05 | $610 | 2006 May 12 |
| GDBA Investments LLLP | 10% Owner | Buy | 1,200 | $4.13 | $4,950 | 2005 Dec 30 |
Take AARD further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put AARD in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Aardvark Therapeutics, Inc. next reports.
Set alerts on AARD
Get notified when Aardvark Therapeutics, Inc. hits your price targets or technical conditions are met.
Get Started Free